0001209191-17-041327.txt : 20170622 0001209191-17-041327.hdr.sgml : 20170622 20170622160353 ACCESSION NUMBER: 0001209191-17-041327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170616 FILED AS OF DATE: 20170622 DATE AS OF CHANGE: 20170622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gregory Philip D CENTRAL INDEX KEY: 0001343543 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 17925109 MAIL ADDRESS: STREET 1: POINT RICHMOND TECH CENTER II STREET 2: 501 CANAL BOULEVARD SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-16 0 0001293971 bluebird bio, Inc. BLUE 0001343543 Gregory Philip D C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Common Stock 2017-06-16 4 S 0 2445 109.0142 D 33334 D Common Stock 2017-06-16 4 S 0 850 110.0529 D 32484 D Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units. The range in prices for the transaction reported on this line was $108.60 to $109.55. The average weighted price was $109.0142. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The range in prices for the transaction reported on this line was $109.70 to $110.10. The average weighted price was $110.0529. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Jason F. Cole, Attorney-in-Fact 2017-06-22